Bayban’s Medtronic MDT Stock Holding History

Bayban’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.2K	Hold	1,064	–	–	0.06%	180
2026 Q1	$92.2K	Buy	1,064 +64	+6%	+$6.13K	0.08%	172
2025 Q4	$96.1K	Buy	+1,000	New	+$97.1K	0.08%	168

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bayban's MDT Position: Q2 2026 in Review

Bayban held its Medtronic (MDT) position steady in Q2 2026 at 1,064 shares worth $83.2K. The position accounts for 0.06% of the portfolio, ranked #180.

Bayban first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $96.1K in Q4 2025. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Bayban held 1,064 shares of Medtronic worth $83.2K as of Q2 2026.
Bayban left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.06% of Bayban's portfolio in Q2 2026, its #180 holding.
Bayban first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
Bayban's Medtronic position peaked at $96.1K in Q4 2025.
2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.